Aeglea Bio Stock Forecast - Relative Strength Index

AGLEDelisted Stock  USD 0.59  0.01  1.72%   
Aeglea Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Aeglea Bio stock prices and determine the direction of Aeglea Bio Therapeutics's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Aeglea Bio's historical fundamentals, such as revenue growth or operating cash flow patterns.
  
On July 20, 2023 Aeglea Bio Therapeutics had Relative Strength Index of 79.66.
Check Aeglea Bio VolatilityBacktest Aeglea BioTrend Details  

Aeglea Bio Trading Date Momentum

On July 21 2023 Aeglea Bio Therapeutics was traded for  0.59  at the closing time. The top price for the day was 0.62  and the lowest listed price was  0.58 . The trading volume for the day was 636.3 K. The trading history from July 21, 2023 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 1.67% . The overall trading delta against the current closing price is 3.33% .
Compare Aeglea Bio to competition

View Aeglea Bio Related Equities

 Risk & Return  Correlation

Aeglea Bio Market Strength Events

Market strength indicators help investors to evaluate how Aeglea Bio stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Aeglea Bio shares will generate the highest return on investment. By undertsting and applying Aeglea Bio stock market strength indicators, traders can identify Aeglea Bio Therapeutics entry and exit signals to maximize returns.

Aeglea Bio Risk Indicators

The analysis of Aeglea Bio's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Aeglea Bio's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting aeglea stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Other Consideration for investing in Aeglea Stock

If you are still planning to invest in Aeglea Bio Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aeglea Bio's history and understand the potential risks before investing.
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories